|
US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
|
NZ209308A
(en)
|
1983-08-30 |
1991-08-27 |
Genentech Inc |
Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4882317A
(en)
|
1984-05-10 |
1989-11-21 |
Merck & Co., Inc. |
Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
|
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
|
NZ230423A
(en)
|
1988-08-25 |
1993-08-26 |
Liposome Co Inc |
A dosage form comprising an antigen and a multilamellar liposome comprising dimyristolyphosphatidylcholine (dmpc) and cholesterol
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
EP0482068A1
(en)
|
1989-07-14 |
1992-04-29 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
|
DE69133334T2
(de)
|
1990-08-23 |
2004-05-13 |
University Of North Carolina At Chapel Hill |
Transferrin bindende proteine aus neisseria-gonorrhoeae und neisseria-meningitidis
|
|
US5912336A
(en)
|
1990-08-23 |
1999-06-15 |
University Of North Carolina At Chapel Hill |
Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
|
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
SG46492A1
(en)
|
1991-03-01 |
1998-02-20 |
Minnesota Mining & Mfg |
1-Substituted 2-substituted 1H-imidazo [4,5-c] quinolin-4-amines
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
FR2682041B1
(fr)
|
1991-10-03 |
1994-01-14 |
Pasteur Merieux Serums Vaccins |
Vaccin contre les infections a neisseria meningitidis.
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
JP3368902B2
(ja)
|
1992-03-02 |
2003-01-20 |
カイロン エセ．ピー．アー． |
ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
FR2692592B1
(fr)
|
1992-06-19 |
1995-03-31 |
Pasteur Merieux Serums Vacc |
Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
ATE190502T1
(de)
|
1993-05-13 |
2000-04-15 |
American Cyanamid Co |
Herstellung und verwendungen von los-verminderten aussenmembran-proteinen von gram-negativen kokken
|
|
DK0708772T3
(da)
|
1993-07-15 |
2000-09-18 |
Minnesota Mining & Mfg |
Imidazo[4,5,-c]pyridin-4-aminer
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
DE69529219T2
(de)
|
1994-07-01 |
2003-11-06 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Helicobacter proteine und impstoffe
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US6180111B1
(en)
|
1995-05-18 |
2001-01-30 |
University Of Maryland |
Vaccine delivery system
|
|
DK0909323T3
(da)
|
1996-01-04 |
2007-05-21 |
Novartis Vaccines & Diagnostic |
Helicobacter pylori-bakterioferritin
|
|
DE19630390A1
(de)
|
1996-07-26 |
1998-01-29 |
Chiron Behring Gmbh & Co |
Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung
|
|
WO1998040100A1
(en)
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
ATE384130T1
(de)
|
1997-08-21 |
2008-02-15 |
Nederlanden Staat |
Neue mutanten der gram-negativen mukosalen bakterien und ihre verwendung als impfstoffe
|
|
EP2278006A3
(en)
|
1997-11-06 |
2011-03-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
|
CA2307846A1
(en)
|
1997-11-21 |
1999-06-03 |
Genset S.A. |
Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
EP2228384A1
(en)
|
1997-11-28 |
2010-09-15 |
Merck Serono Biodevelopment |
Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
|
|
GB9726398D0
(en)
|
1997-12-12 |
1998-02-11 |
Isis Innovation |
Polypeptide and coding sequences
|
|
DK1047784T4
(en)
|
1998-01-14 |
2015-06-15 |
Novartis Vaccines & Diagnostic |
NEISSERA meningitidis ANTIGENS
|
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
|
TR200002930T2
(tr)
|
1998-04-09 |
2000-12-21 |
Smithkline Beecham Biologicals S.A. |
Kolaylaştırıcı kompozisyonlar
|
|
MX343752B
(es)
|
1998-05-01 |
2016-11-22 |
Novartis Vaccines & Diagnostics Inc |
Antigenos de neisseria meningitidis y composiciones que los contienen.
|
|
GB9810276D0
(en)
|
1998-05-13 |
1998-07-15 |
Smithkline Beecham Biolog |
Novel compounds
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
WO2000010599A2
(en)
|
1998-08-19 |
2000-03-02 |
North American Vaccine, Inc. |
IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
|
|
AU1202200A
(en)
|
1998-10-09 |
2000-05-01 |
Chiron Corporation |
Neisseria genomic sequences and methods of their use
|
|
US7357936B1
(en)
|
1998-10-16 |
2008-04-15 |
Smithkline Beecham Biologicals, Sa |
Adjuvant systems and vaccines
|
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
|
JP2002529069A
(ja)
|
1998-11-12 |
2002-09-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
クラミジア・ニューモニエのゲノム配列
|
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
|
IL144084A0
(en)
|
1999-02-03 |
2002-05-23 |
Biosante Pharmaceuticals Inc |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
EP1162999B1
(en)
|
1999-03-19 |
2006-11-29 |
Glaxosmithkline Biologicals S.A. |
Vaccine against Streptococcus pneumoniae
|
|
DK1459766T3
(da)
|
1999-03-26 |
2008-10-13 |
Vical Inc |
Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
|
|
CA2365914A1
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
JP2003518363A
(ja)
|
1999-04-30 |
2003-06-10 |
カイロン エセ．ピー．アー． |
保存されたナイセリア抗原
|
|
EP1605061A1
(en)
|
1999-04-30 |
2005-12-14 |
Chiron Corporation |
Neisseria genomic sequences and methods of their use
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
IL148672A0
(en)
|
1999-09-24 |
2002-09-12 |
Smithkline Beecham Biolog |
Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
|
AU766635B2
(en)
|
1999-09-24 |
2003-10-23 |
Smithkline Beecham Biologicals (Sa) |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
|
MXPA02003108A
(es)
|
1999-09-25 |
2003-10-14 |
Univ Iowa Res Found |
Acidos nucleicos inmunoestimuladores.
|
|
AU1917501A
(en)
|
1999-11-12 |
2001-06-06 |
University Of Iowa Research Foundation, The |
Control of neisserial membrane synthesis
|
|
NZ520466A
(en)
|
2000-01-17 |
2003-09-26 |
Chiron S |
Outer membrane vesicle (OMV) vaccine comprising n. meningitidis serogroup B outer membrane proteins
|
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
|
ATE503837T1
(de)
|
2000-02-28 |
2011-04-15 |
Novartis Vaccines & Diagnostic |
Hybride expression neisserscher proteine
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
AU2001276619A1
(en)
|
2000-07-03 |
2002-01-14 |
Chiron S.P.A. |
Immunisation against chlamydia pneumoniae
|
|
GB0017149D0
(en)
|
2000-07-12 |
2000-08-30 |
Chiron Spa |
Helicobacter pylori mutants
|
|
WO2002009643A2
(en)
|
2000-07-27 |
2002-02-07 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
|
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
PT1313734E
(pt)
|
2000-09-01 |
2010-02-09 |
Novartis Vaccines & Diagnostic |
Derivados aza heterocíclicos e sua utilização terapêutica
|
|
DE60132937T2
(de)
|
2000-09-11 |
2009-02-12 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Verfahren zur Herstellung von Benzimidazol-2-yl -Chinolinonderivaten
|
|
DE60132471T2
(de)
|
2000-09-26 |
2009-01-15 |
Idera Pharmaceuticals, Inc., Cambridge |
Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
|
|
EP1328543B1
(en)
|
2000-10-27 |
2009-08-12 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
UA75622C2
(en)
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
BR0214407A
(pt)
|
2001-11-27 |
2004-10-19 |
Anadys Pharmaceuticals Inc |
Compostos, composições farmacêuticas e método de modulação das imunoatividades da citocina
|
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
WO2003080678A1
(en)
*
|
2002-03-26 |
2003-10-02 |
Chiron Srl |
Modified saccharides having improved stability in water
|
|
RU2338753C2
(ru)
*
|
2002-03-26 |
2008-11-20 |
Новартис Вэксинес Энд Дайэгностикс С.Р.Л. |
Модифицированные сахариды, имеющие улучшенную стабильность в воде
|
|
DK1499311T3
(da)
|
2002-03-29 |
2010-03-08 |
Novartis Vaccines & Diagnostic |
Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
|
|
DE60328481D1
(de)
*
|
2002-05-14 |
2009-09-03 |
Novartis Vaccines & Diagnostic |
Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
|
|
WO2003101949A2
(en)
|
2002-05-29 |
2003-12-11 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
|
DE20321889U1
(de)
|
2002-08-02 |
2012-03-12 |
Glaxosmithkline Biologicals S.A. |
Impfstoffzusammensetzung
|
|
KR20050038631A
(ko)
|
2002-08-23 |
2005-04-27 |
카이론 코포레이션 |
글리코겐 신타제 키나제 3의 피롤 기제 억제제
|
|
GB0220198D0
(en)
*
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
|
ATE492288T1
(de)
|
2002-10-11 |
2011-01-15 |
Novartis Vaccines & Diagnostic |
Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
AU2003300021A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
EP1594524B1
(en)
|
2003-01-21 |
2012-08-15 |
Novartis Vaccines and Diagnostics, Inc. |
Use of tryptanthrin compounds for immune potentiation
|
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
GB0323103D0
(en)
*
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
PL1742659T3
(pl)
|
2004-04-05 |
2013-08-30 |
Zoetis Services Llc |
Poddane mikrofluidyzacji emulsje typu olej w wodzie oraz kompozycje szczepionek
|
|
EP1765313A2
(en)
|
2004-06-24 |
2007-03-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compounds for immunopotentiation
|
|
GB0502095D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
|
GB0505518D0
(en)
*
|
2005-03-17 |
2005-04-27 |
Chiron Srl |
Combination vaccines with whole cell pertussis antigen
|
|
ES2533248T3
(es)
*
|
2005-05-06 |
2015-04-08 |
Novartis Ag |
Inmunógenos para vacunas contra Meningitidis A
|